Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Elanix Biotechnologies AG Director's Dealing 2017

Jun 19, 2017

136_dirs_2017-06-19_7a53f8c5-e0df-481a-adc4-f3cc8866b917.html

Director's Dealing

Open in viewer

Opens in your device viewer

News Details

Directors’ Dealings | 19 June 2017 18:40

DGAP-DD: Elanix Biotechnologies AG english

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

19.06.2017 / 18:39

The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:
First name: Tomas
Last name(s): Svoboda

2. Reason for the notification

a) Position / status

Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Elanix Biotechnologies AG

b) LEI

391200SYNFFL0NPAJK90

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type: Share
ISIN: DE000A0WMJQ4

b) Nature of the transaction

Disposal

c) Price(s) and volume(s)

Price(s) Volume(s)
5.30 EUR 7261.00 EUR
5.30 EUR 7950.00 EUR
5.30 EUR 5300.00 EUR
5.40 EUR 8100.00 EUR

d) Aggregated information

Price Aggregated volume
5.3279 EUR 28611.0000 EUR

e) Date of the transaction

2017-06-15; UTC+2

f) Place of the transaction

Name: Frankfurt Stock Exchange
MIC: XFRA

19.06.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language: English
Company: Elanix Biotechnologies AG
Domstr. 22
14482 Potsdam
Germany
End of News DGAP News Service

show this